Prevalence of Multidrug-Resistant Enterobacteriaceae Causing Urinary Tract Infection

Authors

  • Nottakaran Amanullah Fairoz Banu Postgraduate Student, Department of Microbiology, Sree Balaji Medical College and Hospital, Chennai, Tamil Nadu, India

Keywords:

urinary tract infection, multidrug resistance, Enterobacteriaceae, injudicious, morbidity, mortality

Abstract

Urinary tract infections are one of the most common causes of hospital admission, high morbidity and mortality. The most common cause of urinary tract infection is Gram-negative bacteria such as Escherichia coli, Proteus spp., Pseudomonas aeruginosa, Acinetobacter spp., Klebsiella spp., Enterobacter spp., Citrobacter spp. and Gram-positive bacteria such as Enterococcus spp., Staphylococcus aureus and Coagulase-negative Staphylococci. Multidrug-resistant Enterobacteriaceae are emerging worldwide due to high empiric and injudicious use of antibiotics. The aim of our study was to evaluate the prevalence of multidrug-resistant Enterobacteriaceae causing urinary tract infection. A total of 503 urine samples (early morning clean catch midstream urine) were received from various departments. Of 186 samples, 78 strains were Escherichia coli (58.6%), 42 were Klebsiella spp. (31.5%), six were Citrobacter spp. (4.51%), five were Proteus spp. (3.75%), one was Enterobacter (0.75%) and one was Provedencia (0.75%). Of 133 isolates, 16 (12.03%) isolates were multidrug resistant. Among the multidrug resistant isolates, five were Escherichia coli, 11 were Klebsiella spp. and one was Proteus spp. Among 16 multidrug resistant isolates, all 16 isolates were sensitive to Tigecycline, 15 isolates were sensitive to Colistin, two isolates were sensitive to Amikacin, three isolates were sensitive to Chloramphenicol and one isolate was sensitive to Tetracycline.

 

Author Biography

  • Nottakaran Amanullah Fairoz Banu, Postgraduate Student, Department of Microbiology, Sree Balaji Medical College and Hospital, Chennai, Tamil Nadu, India
    Microbiology , post graduate.

References

Alqasim A, Jaffal AA, Alyousef AA. Prevalence of Multidrug Resistance and Extended-Spectrum β-Lactamase. Carriage of Clinical Uropathogenic Escherichia coli Isolates in Riyadh, Saudi Arabia. International Journal of Microbiology. 2018; 2018: 9p. Article ID 3026851.

Jagadeeswaran G, Ansari MZ, Rajangam T. Urinary tract infection in diabetics - A five year retrospective study on the prevalence of bacterial isolates and its antibiotic susceptibility patterns in a tertiary care hospital in South India. International Journal of Contemporary Medical Research. 2018; 5(4): 44–45p.

Ahmed SS, Shariq A, Alsalloom AA, Babikir IH, Alhomoud BN. Uropathogens and their antimicrobial resistance patterns: Relationship with urinary tract infections. International Journal of Health Sciences. 2019; 13(2) 48–55p.

Karzan MJ, Faeza BO, Shahida NY. Isolation and identification of urinary tract infectious bacteria exploring their anti-drug potential against some common antibiotics. J Microb Biochem Technol. 2017; 9: 6p. DOI: 10.4172/1948-5948.1000379.

Mazzariol A, Bazaj A, Cornaglia G. Multidrug-resistant Gram-negative bacteria causing urinary tract infections: A review. Journal of Chemotherapy. 2017; 29(Supp1): 2–9p, DOI: 10.1080/1120009X.2017.1380395.

Gutema T, Weldegebreal F, Marami D, Teklemariam Z. Prevalence, antimicrobial susceptibility pattern, and associated factors of urinary tract infections among adult at Metu Karl Heinz Referral Hospital, Southwest Ethiopia. International Journal of Microbiology. 2018; 2018: 7p. Article ID 7591259.

Khawcharoenporn T, Vasoo S, Singh K. Urinary tract infections due to multidrug-resistant Enterobacteriaceae: Prevalence and risk factors in a Chicago Emergency Department. Emergency Medicine International. 2013; 2013: 7p. Article ID 258517.

Leski TA, Taitt CR, Bangura U, Stockelman MG, Ansumana R, Cooper WH, Stenger DA, Vora GJ. High prevalence of multidrug resistant Enterobacteriaceae isolated from outpatient urine samples but not the hospital environment in Bo, Sierra Leone. BMC Infectious Diseases. 2016; 16: 167p. DOI 10.1186/s12879-016-1495-1.

Downloads

Published

2021-08-19

Issue

Vol. 11 No. 2 (2021)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.